GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach-Reference-Cited by-同舟云学术

GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach

Published:2015-08-21 Issue:6 Volume:52 Page:1129-1133
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Crisci Isabella,Aragona Michele,Politi Konstantina Savvina,Daniele Giuseppe,Del Prato Stefano

Funder

Fondazione Diabete Ricerca-MSD

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00592-015-0800-6.pdf

Reference22 articles.

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38:140–149

2. Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17:819–837

3. Bruttomesso D, Fongher C, Silvestri B, Barberio S, Marescotti MC, Iori E, Valerio A, Crazzolara D, Pianta A, Tiengo A, Del Prato S (2001) Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients. Diab Res Clin Pract 51:97–105

4. Kielgast U, Holst JJ, Madsbad S (2009) Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists. Curr Diabetes Rev 5:266–275

5. Kuhaydiya ND, Malik R, Bellini NJ et al (2013) Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus. EndocrPract 19:963–967

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Success story of GLP-1 agonist (Liraglutide) treatment in someone with type 1 diabetes: a life transformed;Cardiovascular Endocrinology & Metabolism;2023-09-28

2. Glucose and HbA1c variability and time in range (TIR);Die Diabetologie;2022-12-05

3. Glukose- und HbA1c-Variabilität sowie Zeit im Zielbereich (TIR);Die Diabetologie;2022-12-05

4. Glycaemic management in diabetes: old and new approaches;The Lancet Diabetes & Endocrinology;2022-01

5. Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis;Current Diabetes Reviews;2020-04-28